The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT02767401
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT02767401
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02767401. Non-randomized; no masking; primary purpose treatment. Start 2015-09-15 (actual); primary completion 2018-08-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Success of Opening Single CTO Lesions to Improve Myocardial Viability Study (SOS-comedy)
- Condition
- Hibernation, Myocardial
- Condition
- Complete Occlusion of Coronary Artery
- Intervention (Device)
- stenting or balloon expansion
- Intervention (Drug)
- aspirin, clopidogrel, ticagrelor, atorvastatin, rosuvastatin, betaloc
- Lead sponsor
- The First Affiliated Hospital of Dalian Medical University
- Collaborator
- Beijing Anzhen Hospital
- Collaborator
- First Hospital of China Medical University
- Collaborator
- Nanfang Hospital, Southern Medical University
Record details
- Record id
cardio:ct-nct02767401- Content hash
75322e065e50532969a8d8d857d0ac3eec26edfc46a8eeccfa4e6244f9a20cc7